Literature DB >> 12137815

Recurrent kidney stone: a 25-year follow-up study in persons with spinal cord injury.

Yuying Chen1, Michael J DeVivo, Samuel L Stover, L Keith Lloyd.   

Abstract

OBJECTIVES: To document the recurrence rate of kidney stones in patients with spinal cord injury and to assess the potential contributing factors and long-term renal function outcome.
METHODS: A consecutive sample of 77 patients with initial kidney stones followed up on a yearly basis between 1973 and 1999 was used to estimate stone recurrence, stratified by demographic and clinical characteristics. Longitudinal data analyses were performed to assess the change in renal function over time among various post-treatment outcomes.
RESULTS: During an average of 7 years (range 1 to 21) of follow-up after the initial stone episode, 19 patients with recurrence, 15 with residual stones, and 43 who were stone free were documented. It was estimated that approximately 34% of the patients with an initial stone would develop a second stone episode within 5 years. This figure did not significantly change during the past 25 years (P = 0.18). Stone recurrence was two or more times greater for men than for women, for whites than for blacks, and for tetraplegics than for paraplegics, but the differences were not statistically significant (P >0.05). Renal function did not significantly decline over time for any of the post-treatment outcomes of the initial stones.
CONCLUSIONS: Despite marked improvement in urologic rehabilitation, little progress has been made during the past 25 years in reducing stone recurrence in persons with spinal cord injury. Future studies are required to determine the critical components of the causal pathway to stone formation, which may lead to the establishment of effective prophylactic interventions.

Entities:  

Mesh:

Year:  2002        PMID: 12137815     DOI: 10.1016/s0090-4295(02)01734-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Outcomes of percutaneous nephrolithotomy in spinal cord injury patients as compared to a matched cohort.

Authors:  Kristin G Baldea; Robert H Blackwell; Srikanth Vedachalam; Anai N Kothari; Paul C Kuo; Gopal N Gupta; Thomas M T Turk
Journal:  Urolithiasis       Date:  2016-12-20       Impact factor: 3.436

2.  Flexible ureteroscopic laser lithotripsy for upper urinary tract stone disease in patients with spinal cord injury.

Authors:  Abdulkadir Tepeler; Brian C Sninsky; Stephen Y Nakada
Journal:  Urolithiasis       Date:  2015-05-19       Impact factor: 3.436

Review 3.  Surgical management of urolithiasis in spinal cord injury patients.

Authors:  Philippe Nabbout; Gennady Slobodov; Daniel J Culkin
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

4.  The change in upper tract urolithiasis composition, surgical treatments and outcomes of para and quadriplegic patients over time.

Authors:  Marisa M Clifton; Matthew T Gettman; David E Patterson; Laureano Rangel; Amy E Krambeck
Journal:  Urolithiasis       Date:  2014-07-12       Impact factor: 3.436

5.  Percutaneous nephrolithotomy in prone position in patients with spinal deformities.

Authors:  Volkan Izol; Ibrahim Atilla Aridogan; Ali Borekoglu; Fatih Gokalp; Zehra Hatipoglu; Yildirim Bayazit; Sinan Zeren
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Description of Urological Surveillance and Urologic Ultrasonography Outcomes in a Cohort of Individuals with Long-Term Spinal Cord Injury.

Authors:  Jacinthe J E Adriaansen; Floris W A van Asbeck; Helma M H Bongers-Janssen; Dorien Spijkerman; Johanna M A Visser-Meily; Laetitia M O de Kort; Marcel W M Post
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

Review 7.  Neurogenic bladder in spinal cord injury patients.

Authors:  Waleed Al Taweel; Raouf Seyam
Journal:  Res Rep Urol       Date:  2015-06-10

8.  Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.

Authors:  Kai Wang; Jing Ge; Wenlong Han; Dong Wang; Yinjuan Zhao; Yanhao Shen; Jiexun Chen; Dongming Chen; Jing Wu; Ning Shen; Shuai Zhu; Bin Xue; Xianlin Xu
Journal:  BMC Urol       Date:  2022-04-19       Impact factor: 2.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.